Skip Navigation


Human Molecular Genetics Advance Access originally published online on January 24, 2006
Human Molecular Genetics 2006 15(5):797-805; doi:10.1093/hmg/ddi494
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
15/5/797    most recent
ddi494v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (50)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ho, G.-T.
Right arrow Articles by Satsangi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, G.-T.
Right arrow Articles by Satsangi, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach

G.-T. Ho1,*, N. Soranzo3, E.R. Nimmo1, A. Tenesa2, D.B. Goldstein3 and J. Satsangi1

1Molecular Medicine Unit and Gastrointestinal Unit, University of Edinburgh and 2MRC Human Genetics Unit, Western General Hospital, Edinburgh, UK and 3Goldstein Laboratories, Darwin Building, University College London, London, UK

* To whom correspondence should be addressed at: Gastrointestinal Unit, Western General Hospital, Edinburgh EH4 2XU, UK. Tel: +44 1315371769; Fax: +44 1315371007; Email: gwotzerho{at}aol.com

Received October 1, 2005; Accepted January 18, 2006

Several lines of evidence suggest a role for the multidrug resistance gene (ABCB1/MDR1) and its product, P-glycoprotein 170, in the pathogenesis of inflammatory bowel disease (IBD). In addition, P-glycoprotein activity determines bioavailability of many drugs used regularly in many medical specialities, and ABCB/MDR1 variation appears to be a critical pharmacogenetic determinant. We have utilized a gene-wide haplotype tagging approach to further define the identity of germ-line variations in the ABCB1/MDR1 gene contributing to IBD susceptibility. Six haplotype tagging single nucleotide polymorphisms (tSNPs) representing the haplotypic variations of the ABCB1/MDR1 gene were identified initially following the characterization of the haplotype structure of this gene in 24 Centre d'Etude du Polymorphisme Humain Caucasian trios. Genotyping was performed in 249 ulcerative colitis (UC) and 179 Crohn's disease (CD) patients and 260 healthy controls. Using log-likelihood analysis, we observed a highly significant association between the common haplotypes and UC (P=4.22x10–7) but not CD (P=0.22). This significant association was critically dependent on one tSNP, intronic variant rs3789243. All haplotypes with this variant retained a highly significant association (P=3.2x10–7–3.6x10–12), whereas significance was lost when rs3789243 was dropped in systematic haplotypic analysis. The effect of this tSNP was independent of C3435T SNP, previously suggested to be the critical variant in disease susceptibility and drug transport. The association with UC was shown to be strongest with the phenotype of extensive disease (P=1.7x10–7). This ‘candidate gene’ approach provides compelling evidence to support the contribution of the ABCB1/MDR1 gene in determining risk to UC but not to CD and provides new insights into the localization of the critical susceptibility determinants within the gene. In addition, these findings have potentially important implications in the application of pharmacogenetics across a range of common diseases, including HIV, epilepsy and colorectal cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GutHome page
C L Noble, A R Abbas, J Cornelius, C W Lees, G-T Ho, K Toy, Z Modrusan, N Pal, F Zhong, S Chalasani, et al.
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis
Gut, October 1, 2008; 57(10): 1398 - 1405.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
O. Levran, K. O'Hara, E. Peles, D. Li, S. Barral, B. Ray, L. Borg, J. Ott, M. Adelson, and M. J. Kreek
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence
Hum. Mol. Genet., July 15, 2008; 17(14): 2219 - 2227.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M C Wapenaar, A J Monsuur, A A van Bodegraven, R K Weersma, M R Bevova, R K Linskens, P Howdle, G Holmes, C J Mulder, G Dijkstra, et al.
Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitisAn unusual case of ascites
Gut, April 1, 2008; 57(4): 463 - 467.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Van Limbergen, E. R. Nimmo, R. K. Russell, H. E. Drummond, L. Smith, N. H. Anderson, G. Davies, I. D. Arnott, D. C. Wilson, and J. Satsangi
Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy
Hum. Mol. Genet., September 15, 2007; 16(18): 2175 - 2186.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. V. Raelson, R. D. Little, A. Ruether, H. Fournier, B. Paquin, P. Van Eerdewegh, W. E. C. Bradley, P. Croteau, Q. Nguyen-Huu, J. Segal, et al.
From the Cover: Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci
PNAS, September 11, 2007; 104(37): 14747 - 14752.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G-T Ho, N Soranzo, S K Tate, H Drummond, E R Nimmo, A Tenesa, I D Arnott, and J Satsangi
Lack of association of the pregnane X receptor (PXR/NR1I2) gene with inflammatory bowel disease: parallel allelic association study and gene wide haplotype analysis.
Gut, November 1, 2006; 55(11): 1676 - 1677.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.